From the publishers of JADPRO
Graft-vs.-Host Disease
Resource Center
Menu
Resources
Videos
Videos
Quizzes
News & Literature Highlights
Case Studies
Advertisement
Interview With Caroline Pearson, NP, MSN, RN: Treating Steroid-Refractory Acute GVHD
Last Updated: Wednesday, May 17, 2023
Advertisement
News & Literature Highlights
Pediatric Blood & Cancer
Prophylactic donor lymphocyte infusion after haploidentical hematopoietic cell transplantation and post-transplant cyclophosphamide for treatment of high-risk myeloid neoplasms in children: A retrospective study
Bone Marrow Transplantation
Acute GVHD classification based on the dynamics of GVHD skin involvement from its appearance to the start of systemic treatment
Regulatory Focus
FDA guidance explores trial design, supporting data for GVHD treatments
Targeted Oncology
Acute GVHD responds quickly to itolizumab treatment in phase 1b trial
Transplantation and Cellular Therapy
Healthcare resource utilization and costs of steroid-associated complications in patients with graft-versus-host disease
Journal of Clinical Oncology
Naive T-cell depletion to prevent chronic graft-versus-host disease
Blood
A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease
The ASCO Post
Abatacept for prophylaxis of acute graft-vs-host disease
Translation and Cellular Therapy
A phase I trial of SYK inhibition with fostamatinib in the prevention and treatment of chronic graft-versus-host disease
Blood
Prevention of acute GVHD disease using an orthogonal IL-2/IL-2Rβ system to selectively expand regulatory T-cells in vivo
Advertisement
Case Studies
Elevated Bilirubin Following Engraftment: Differentiating SOS/VOD From GVHD
Management of Chronic Oral GVHD in Patient with High-Risk AML and Mixed Chimerism
Patient With History of Acute Steroid-Dependent Skin GVHD Develops Chronic GVHD: Part 2
Advertisement
Quizzes
Test your knowledge on differentiating SOS/VOD from GVHD
Test your knowledge of chronic oral GVHD in patients with high-risk AML and mixed chimerism
Test your knowledge on managing acute steroid-dependent skin GVHD